Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,681
Closed -$160K 161
2025
Q3
$160K Buy
+1,681
New +$155K 0.02% 89
2024
Q2
Sell
-5,017
Closed -$437K 24
2024
Q1
$437K Buy
+5,017
New +$428K 0.07% 20
2023
Q1
Sell
-259
Closed -$20.1K 106
2022
Q4
$20.1K Sell
259
-5,404
-95% -$438K ﹤0.01% 181
2022
Q3
$457K Buy
5,663
+2,063
+57% +$185K 0.04% 249
2022
Q2
$323K Buy
+3,600
New +$365K 0.02% 270
2021
Q4
Sell
-676
Closed -$85K 188
2021
Q3
$85K Buy
+676
New +$87.5K 0.01% 303
2021
Q2
Sell
-144
Closed -$18.1K 284
2021
Q1
$17K Sell
144
-267
-65% -$31.3K ﹤0.01% 231
2020
Q4
$48K Buy
+411
New +$45.2K ﹤0.01% 126

Other funds holding MDT

QVR's MDT Position: Q4 2025 in Review

QVR sold out of Medtronic (MDT) in Q4 2025, closing a stake of 1,681 shares — an estimated $160K sold.

QVR first reported a position in MDT in Q4 2020 and held it in 8 quarters. The position peaked at $457K in Q3 2022. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • QVR reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • QVR sold 1,681 Medtronic shares in Q4 2025, an estimated $160K.
  • QVR first reported a position in Medtronic in Q4 2020 and held it in 8 quarters.
  • QVR's Medtronic position peaked at $457K in Q3 2022.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on QVR's 13F filing for Q4 2025, filed 28 Jan 2026.